# Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin

> **NCT03668639** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Christina Ruhlmann** · enrollment: 80 (estimated)

## Conditions studied

- Chemotherapy-induced Nausea and Vomiting
- Adverse Event
- Cervical Cancer

## Interventions

- **DRUG:** Akynzeo
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03668639
- **Lead sponsor:** Christina Ruhlmann
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-05
- **Primary completion:** 2023-03-01
- **Final completion:** 2023-04-15
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2021-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03668639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03668639, "Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03668639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*